MARMIROLI, Sandra
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.045
AS - Asia 5.063
EU - Europa 4.285
SA - Sud America 624
AF - Africa 130
OC - Oceania 39
Continente sconosciuto - Info sul continente non disponibili 6
Totale 23.192
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.913
SG - Singapore 1.829
GB - Regno Unito 1.691
CN - Cina 1.175
IT - Italia 639
HK - Hong Kong 624
VN - Vietnam 516
BR - Brasile 490
SE - Svezia 424
DE - Germania 339
FI - Finlandia 314
BD - Bangladesh 215
FR - Francia 195
UA - Ucraina 191
RU - Federazione Russa 185
KR - Corea 146
TR - Turchia 133
IN - India 94
BG - Bulgaria 89
ID - Indonesia 66
CA - Canada 54
AR - Argentina 45
MX - Messico 44
BE - Belgio 40
AU - Australia 37
IQ - Iraq 37
AE - Emirati Arabi Uniti 32
ZA - Sudafrica 32
IE - Irlanda 26
NL - Olanda 25
EC - Ecuador 22
JP - Giappone 22
PK - Pakistan 22
CO - Colombia 20
MA - Marocco 20
PH - Filippine 17
AT - Austria 15
CL - Cile 14
NG - Nigeria 14
SA - Arabia Saudita 14
VE - Venezuela 14
IR - Iran 13
MY - Malesia 13
PL - Polonia 13
RO - Romania 13
LT - Lituania 12
UZ - Uzbekistan 12
ES - Italia 11
ET - Etiopia 11
QA - Qatar 9
TN - Tunisia 9
EG - Egitto 7
GT - Guatemala 7
KE - Kenya 7
PY - Paraguay 7
RS - Serbia 7
TH - Thailandia 7
AL - Albania 6
BO - Bolivia 6
BY - Bielorussia 6
DZ - Algeria 6
IL - Israele 6
NP - Nepal 6
OM - Oman 6
PT - Portogallo 6
TW - Taiwan 6
AZ - Azerbaigian 5
CR - Costa Rica 5
GE - Georgia 5
GR - Grecia 5
JO - Giordania 5
LB - Libano 5
NO - Norvegia 5
SN - Senegal 5
CH - Svizzera 4
CZ - Repubblica Ceca 4
MD - Moldavia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AM - Armenia 3
BH - Bahrain 3
DO - Repubblica Dominicana 3
GH - Ghana 3
HU - Ungheria 3
KW - Kuwait 3
KZ - Kazakistan 3
NI - Nicaragua 3
PA - Panama 3
PE - Perù 3
PR - Porto Rico 3
PS - Palestinian Territory 3
SK - Slovacchia (Repubblica Slovacca) 3
SY - Repubblica araba siriana 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
BZ - Belize 2
EU - Europa 2
JM - Giamaica 2
LU - Lussemburgo 2
LV - Lettonia 2
NZ - Nuova Zelanda 2
Totale 23.161
Salva come PNG Salva come JPEG
Città #
Southend 1.274
Singapore 1.222
Fairfield 1.216
Santa Clara 1.143
Ashburn 1.081
Woodbridge 734
Hong Kong 611
Houston 537
San Jose 534
Chandler 519
Chicago 519
Seattle 480
Wilmington 417
Cambridge 387
Jacksonville 369
Hefei 340
Ann Arbor 327
Los Angeles 321
Dearborn 315
Helsinki 242
London 225
Beijing 219
Nyköping 217
Council Bluffs 205
Salt Lake City 196
Ho Chi Minh City 176
San Diego 139
The Dalles 124
Modena 123
Hanoi 107
Seoul 98
Tampa 98
Princeton 90
New York 89
Sofia 88
Elk Grove Village 87
Dallas 80
Moscow 69
Eugene 68
Buffalo 67
Shanghai 66
Milan 64
Lauterbourg 61
Izmir 59
Des Moines 57
Frankfurt am Main 52
Jakarta 52
Bologna 48
Sterling 42
Lancaster 41
Dulles 38
Munich 37
São Paulo 36
Orem 34
Atlanta 31
Phoenix 30
Columbus 29
Haiphong 28
Redwood City 28
Detroit 27
Boardman 26
Grafing 26
Miami 26
Da Nang 25
Dublin 25
Rome 24
Fremont 22
Ghent 22
Tokyo 20
Bremen 19
Chennai 19
Pittsburgh 19
Baghdad 18
Falls Church 18
Kansas City 16
Norwalk 16
Nuremberg 16
Rio de Janeiro 16
Montreal 15
Redondo Beach 14
Brooklyn 13
Brussels 13
Dong Ket 13
Guangzhou 13
Jersey City 13
Amsterdam 12
Johannesburg 12
Mexico City 12
Manchester 11
Belo Horizonte 10
Biên Hòa 10
Boston 10
Dhaka 10
Florence 10
Karachi 10
Kent 10
Toronto 10
Warsaw 10
Brasília 9
Hounslow 9
Totale 16.635
Salva come PNG Salva come JPEG
Nome #
Development of solvent-casting particulate leaching (SCPL) polymer scaffolds as improved three-dimensional supports to mimic the bone marrow niche 492
The protein kinase Akt/PKB regulates both prelamin A degradation and Lmna gene expression 468
Monocytosis has adverse prognostic significance and impacts survival in patients with T-cell lymphomas 443
Feedbacks and adaptive capabilities of the PI3K/Akt/mTOR axis in acute myeloid leukemia revealed by pathway selective inhibition and phosphoproteome analysis 441
Clusterin enhances AKT2-mediated motility of normal and cancer prostate cells through a PTEN and PHLPP1 circuit 434
MATER protein as substrate of PKCepsilon in human cumulus cells. 418
Human MATER localization in specific cell domains of oocytes and follicular cells 407
Anticancer agents sensitize osteosarcoma cells to TNF-related apoptosis-inducing ligand downmodulating IAP family proteins 404
Targeting of the Akt/PKB kinase to the actin skeleton 386
Risk Assessment for Metals and PAHs by Mediterranean Seafood 379
AKT1-mediated Lamin A/C degradation is required for nuclear degradation and normal epidermal terminal differentiation 376
Tumour necrosis factor-related apoptosis-inducing ligand sequentially activates pro-survival and pro-apoptotic pathways in SK-N-MC neuronal cells 373
Effects of mutations in Wnt/β-catenin, hedgehog, Notch and PI3K pathways on GSK-3 activity—Diverse effects on cell growth, metabolism and cancer 369
Pharmacological inhibition of protein kinase CK2 reverts the multidrug resistance phenotype of a CEM cell line characterized by high CK2 level 364
Reversal of the glycolytic phenotype of primary effusion lymphoma cells by combined targeting of cellular metabolism and PI3K/Akt/ mTOR signaling 361
Sensitization of multidrug resistant human ostesarcoma cells to Apo2 Ligand/TRAIL-induced apoptosis by inhibition of the Akt/PKB kinase 354
Ankrd2/ARPP is a novel Akt2 specific substrate andregulates myogenic differentiation upon cellular exposure to H(2)O(2). 354
Aberrant Compartment Formation by HSPB2 Mislocalizes Lamin A and Compromises Nuclear Integrity and Function 352
Inhibition of phosphoinositide 3-kinase impairs pre-commitment cell cycle traverse and prevents differentiation in erythroleukaemia cells. 346
Lamin A Ser404 Is a Nuclear Target of Akt Phosphorylation in C2C12 Cells 345
Cross-talk between the CK2 and AKT signaling pathways in cancer 341
The oral protein-kinase C beta inhibitor enzastaurin (LY317615) suppresses signalling through the AKT pathway, inhibits proliferation and induces apoptosis in multiple myeloma cell lines 336
Nuclear Nox4 interaction with prelamin A is associated with nuclear redox control of stem cell aging 328
Troglitazione affects survival of human osteosarcoma cells 324
Serum fatty acids and risk of cutaneous melanoma: a population-based case-control study 323
Critical Roles of EGFR Family Members in Breast Cancer and Breast Cancer Stem Cells: Targets for Therapy 321
Phosphorylation, Signaling, and Cancer: Targets and Targeting 318
A-type lamins and signaling: the PI 3-kinase/Akt pathway moves forward 318
Dual inhibition of PI3K/mTOR signaling in chemoresistant AMLprimary cells. 316
Phosphatidylinositol 3-kinase translocation to the nucleus is induced by interleukin 1 and prevented by mutation of interleukin 1 receptor in human osteosarcoma Saos-2 cells 312
Deregulated PTEN/PI3K/AKT/mTOR signaling in prostate cancer: Still a potential druggable target? 309
Association of emerin with nuclear and cytoplasmic actin is regulated in differentiating myoblasts 308
Phosphoproteomic analysis reveals hyperactivation of mTOR/STAT3 and LCK/Calcineurin axes in pediatric early T-cell precursor ALL 301
Autophagic degradation of farnesylated prelamin A as a therapeutic approach to lamin-linked progeria. 298
Inhibition of Ras-mediated signaling pathways in CML stem cells 291
Rapamycin treatment of Mandibuloacral dysplasia cells rescues localization of chromatin-associated proteins and cell cycle dynamics 288
Nuclear phospholipase C β1 signaling, epigenetics and treatments in MDS. 279
Phosphatidylinositol 3-kinase is required for the induction of ornithine decarboxylase in leukemia cells stimulated to growth. 276
The need for a reassessment of the safe upper limit of selenium in drinking water 275
Reverse-phase protein microarrays (RPPA) as a diagnosticand therapeutic guide in multidrug resistant leukemia 270
Melanocytes – A novel tool to study mitochondrial dysfunction in Duchenne Muscular Dystrophy 265
Nuclear damages and oxidative stress: new perspectives for laminopathies 257
Crosstalks of GSK3 signaling with the mTOR network and effects on targeted therapy of cancer 257
Dasatinib Plus Nutlin-3 Shows Synergistic Antileukemic Activity inBoth p53wild-type and p53mutated B Chronic Lymphocytic Leukemias by Inhibitingthe Akt Pathway 253
The Oral PKC-ß Inhibitor Enzastaurin (LY317615) Suppress Phosphorylation and Induces Apoptosis in Multiple Myeloma Cell Lines by Inhibition of AKT Pathway. 253
Signaling specificity in the Akt pathway in biology and disease 253
Nuclear PLCβ1 acts as a negative regulator of p45/NF-E2 expression levels in Friend erythroleukemia cells 252
Clusterin enhances migration and invasion of prostate cancer cells through an isoform-specific Akt2/miR-190/PHLPP1 circuit. 251
Nuclear lipid-dependent signal transduction in human osteosarcoma cells. 248
Lamin A N-terminal phosphorylation is associated with myoblast activation: impairment in Emery-Dreifuss muscular dystrophy 245
Influence of selenium on the emergence of neuro tubule defects in a neuron-like cell line and its implications for amyotrophic lateral sclerosis 245
New roles for lamins, nuclear envelope proteins and actin in the nucleus 243
Environmental risk factors for amyotrophic lateral sclerosis: methodological issues in epidemiologic studies 242
Laminopathies and A-type lamin-associated signalling pathways 241
At the nucleus of the problem: Nuclear proteins and disease 239
Tiazofurin induces a down modulation of ICAM-1 expression on K562 target cells impairing NK adhesion and killing. 233
Phosphatidylinositol 3-kinase translocation to the nucleus is an early event in the interleukin-1 signalling mechanism in human osteosarcoma Saos-2 cells. 230
Phosphoinositidase C isozymes in SaOS-2 cells: immunocytochemical detection in nuclear and cytoplasmic compartments. 229
Age-related events in human active T limphocytes. Changes in the phosphoinositidase C activity. 224
Protein kinase B/AKT isoform 2 drives migration of human mesenchymal stem cells. 219
Phosphatidylinositol 3-kinase is recruited to a specific site in the activated IL-1 receptor I. 212
Nuclear protein kinases in rat liver: evidence for increased Histone H1 phosphorylating activity during liver regeneration. 211
Inhibition of the expression of ornithine decarboxylase and c-Myc by cell-permeant ceramide in difluoromethylornithine-resistant leukaemia cells. 209
Transfected Saos-2 cells overexpressing phosphoinositidase C beta1 isoform accumulate it within the nucleus. 187
Unusual laminin alpha2 processing in myoblasts from a patient with a novel variant of congenital muscular dystrophy. 186
An unbiased approach to mapping the signaling network of the pseudorabies virus US3 protein 184
The key role of public health in renovating Italian biomedical doctoral programs 183
Targeting PI3K/Akt/mTOR in AML: Rationale and Clinical Evidence. 177
Synergistic cytotoxicity of dual PI3K/mTOR and FLT3 inhibition in FLT3-ITD AML cells 176
The intranuclear amount of phospholipase C beta1 decreases following cell differentiation in Friend cells, whereas gamma1 isoform is not affected. 173
Interleukin-1alfa stimulates nuclear phosphoinositidase C activity in human osteosarcoma SaOS-2 cells. 170
Interleukin-1-receptor-associated kinase 2 (IRAK2)-mediated interleukin-1-dependent nuclear factor kappa B transactivation in Saos2 cells requires the Akt/protein kinase B kinase 169
Improved efficacy of quizartinib in combination therapy with PI3K inhibition in primary FLT3-ITD AML cells 169
Editorial: Special Issue on Innovative Multi-Disciplinary Approaches for Precision Studies in Leukemia 168
A KDM4A-PAF1-mediated epigenomic network is essential for acute myeloid leukemia cell self-renewal and survival 160
Study on the role of endogenous polyamines in glucagon, isoproterenol or serum-mediated induction of tyrosine aminotransferase in cultured heart cells 146
Mechanisms involved in the promoting activity of fibroblasts in HTLV-1-mediated lymphomagenesis: Insights into the plasticity of lymphomatous cells 140
Critical role of protein kinase CK2 in chronic myeloid leukemia cells harboring the T315I BCR::ABL1 mutation 129
A different involvement of polyamines in the induction of tyrosine aminotransferase by glucagon, isoproterenol or serum in cultured heart cells 122
Involvement of thiol transferase- and thioredoxin-dependent systems in the protection of 'essential' thiol groups of ornithine decarboxylase 118
Editor's Note: Dasatinib Plus Nutlin-3 Shows Synergistic Antileukemic Activity in Both p53wild-type and p53mutated B Chronic Lymphocytic Leukemias by Inhibiting the Akt Pathway 116
Effect of ATP depletion and phenanthroline on the spermidine-mediated decay of ornithine decarboxylase in erythroleukemia cells 113
Stabilization of ornithine decarboxylase in erythroleukemia cells depleted of ATP 113
Effect of sodium arsentie on the induction and turnover of ornithine decarboxylase activity in erythroleukemia cells 103
Immunocytochemical detection of the specific association of different PIC isoforms with cytoskeletal and nuclear matrix compartments in PC12 cells 103
IL-1 receptor signalling mechanism in SAOS-2 osteosarcoma cells 100
Phosphorylation of ornithine decarboxylase in intact erythroleukemia cells 100
Inositol lipid phosphorylation and breakdown in rat liver nuclei is affected by hydrocortisone blood levels 94
Regulation of hormonal sensitivity of cardiac cells in culture by polyamines 89
Inhibition of rat heart ornithine decarboxylase by basic polypeptides 85
NFATc1 and NFATc2 regulate glucocorticoid resistance in pediatric T-cell acute lymphoblastic leukemia through modulation of cholesterol biosynthesis and the WNT/β-catenin pathway 28
Totale 23.310
Salva come PNG Salva come JPEG
Categoria #
all - tutte 98.867
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 98.867
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021107 0 0 0 0 0 0 0 0 0 0 0 107
2021/20221.889 72 227 223 147 28 83 128 119 144 124 435 159
2022/20231.498 180 150 133 121 158 231 34 153 211 5 64 58
2023/20241.052 37 45 54 128 212 77 148 133 43 27 36 112
2024/20253.680 97 35 48 208 764 625 182 239 396 178 408 500
2025/20268.182 429 244 460 1.175 2.186 533 873 279 686 518 404 395
Totale 23.310